Irska - angleščina - HPRA (Health Products Regulatory Authority)

lexon pharmaceuticals (ireland) limited - ciclopirox olamine - shampoo - other antifungals for topical use; ciclopirox

Irska - angleščina - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - benzoyl peroxide hydrous, clindamycin phosphate - gel - 10 + 30 mg/g - antiinfectives for treatment of acne

Kanada - angleščina - Health Canada

stiefel laboratories (ireland) limited - podophyllotoxin - liquid - 5mg - podophyllotoxin 5mg - misc. skin and mucous membrane agents

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

5% and 1%) (stiefel laboratories (uk) ltd - benzoyl peroxide; clindamycin phosphate - cutaneous gel - 50mg/1gram ; 10mg/1gram

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

3% and 1%) (stiefel laboratories (uk) ltd - clindamycin phosphate; benzoyl peroxide - cutaneous gel - 10mg/1gram ; 30mg/1gram

Malta - angleščina - Medicines Authority

glaxo smithkline ireland limited 12, riverwalk, citywest business campus, dublin 24, ireland - benzoyl peroxide, hydrous, clindamycin phosphate - gel - benzoyl peroxide hydrous 30 mg/g clindamycin phosphate 10 mg/g - anti-acne preparations

Singapur - angleščina - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - benzoyl peroxide hydrous; clindamycin phosphate - gel - 6.67% w/w - benzoyl peroxide hydrous 6.67% w/w; clindamycin phosphate 1.28% w/w

Južnoafriška republika - angleščina - South African Health Products Regulatory Authority (SAHPRA)

stiefel -

Združene države Amerike - angleščina - NLM (National Library of Medicine)

stiefel laboratories inc - acitretin (unii: lch760e9t7) (acitretin - unii:lch760e9t7) - acitretin 10 mg - soriatane is indicated for the treatment of severe psoriasis in adults. because of significant adverse effects associated with its use, soriatane should be prescribed only by those knowledgeable in the systemic use of retinoids. in females of reproductive potential, soriatane should be reserved for non-pregnant patients who are unresponsive to other therapies or whose clinical condition contraindicates the use of other treatments (see boxed contraindications and warnings — soriatane can cause severe birth defects). most patients experience relapse of psoriasis after discontinuing therapy. subsequent courses, when clinically indicated, have produced efficacy results similar to the initial course of therapy. see boxed contraindications and warnings. soriatane is contraindicated in patients with severely impaired liver or kidney function and in patients with chronic abnormally elevated blood lipid values (see boxed warnings:hepatotoxicity, warnings:lipids and possible cardiovascular effects, and precautions). an

Malta - angleščina - Medicines Authority

glaxo smithkline uk limited - benzoyl peroxide; clindamycin - gel - benzoyl peroxide 50 mg/g; clindamycin 10 mg/g - anti-acne preparations